Page last updated: 2024-12-05

dibutyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Dibutyl ether, also known as butyl ether, is a colorless liquid with a sweet odor. It is a highly flammable and volatile organic compound. It is commonly used as a solvent in many industrial applications, including paint thinners, degreasers, and extraction processes. Dibutyl ether is synthesized through the Williamson ether synthesis, reacting sodium butoxide with 1-bromobutane. It is also produced as a byproduct during the production of other chemicals. Dibutyl ether is a common component in many laboratory and industrial settings, making its study crucial for understanding its properties, safety considerations, and environmental impact. Research on dibutyl ether focuses on its synthesis, reactivity, toxicity, and environmental fate. It is often studied in the context of its potential for environmental contamination, particularly in soil and water. Researchers are also interested in exploring alternative, less hazardous solvents to replace dibutyl ether due to its flammability and potential health risks.'

Cross-References

ID SourceID
PubMed CID8909
CHEMBL ID48132
SCHEMBL ID15167
MeSH IDM0150978

Synonyms (73)

Synonym
dibutylether
LS-13538
dibutyl ether
di-n-butyl ether
1-butoxybutane
dibutyl oxide
butane,1'-oxybis-
butyl oxide
nsc-8459
butyl ether
nsc8459
wln: 4o4
142-96-1
n-butyl ether
1,1'-oxybisbutane
n-dibutyl ether
ether butylique
butane, 1,1'-oxybis-
1,1'-oxydibutane
inchi=1/c8h18o/c1-3-5-7-9-8-6-4-2/h3-8h2,1-2h
ether butylique [french]
einecs 205-575-3
brn 1732752
nsc 8459
ccris 6010
1,1'-oxybis(butane)
ai3-00402
hsdb 306
dibutyl ether, anhydrous, 99.3%
B0721
1-butoxy-butane
CHEMBL48132
A807991
NCGC00248903-01
ec 205-575-3
pbm2r52p5g ,
4-01-00-01520 (beilstein handbook reference)
unii-pbm2r52p5g
dtxcid002007
NCGC00258590-01
tox21_201037
cas-142-96-1
dtxsid1022007 ,
STL280282
FT-0625171
AKOS015915425
n-butyl ether [mi]
dibutyl ether [hsdb]
SCHEMBL15167
un 1149
(n-c4h9)2o
di-1-butyl ether
din butyl ether
(c4h9)2o
di n-butylether
di-n-butylether
nbu2o
di-n butyl ether
n-bu2o
di(1-butyl) ether
n-butylether
bu2o
J-520373
mfcd00009461
dibutyl ether, reagentplus(r), >=99%
dibutyl ether, purum, >=99.0% (gc)
dibutyl ether, p.a., 99%
J-007726
F0001-0501
Q1207808
AMY30969
di-(1-butyl) ether
EN300-315383
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency10.76030.000714.592883.7951AID1259369
estrogen nuclear receptor alphaHomo sapiens (human)Potency67.89270.000229.305416,493.5996AID1259244
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency67.89270.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency67.89270.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID101345Toxicity determined using Golden Orfe Fish Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 61.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index61.96 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index95.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (61.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]